No paralogue variants have been mapped to residue 533 for KCNH2.
| KCNH2 | -----------------LIGLLKTARLLRL>V<RVARKLDRY-----SEYGAAV-LFLLMCTF | 557 |
| KCNH1 | --IPPPLEGRESQGISSLFSSLKVVRLLRL>G<RVARKLDHY-----IEYGAAV-LVLLVCVF | 386 |
| KCNH3 | --Y-------------FGAHLLKTVRLLRL>L<RLLPRLDRY-----SQYSAVV-LTLLMAVF | 367 |
| KCNH4 | --T-------------SLVHLLKTVRLLRL>L<RLLQKLERY-----SQCSAVV-LTLLMSVF | 369 |
| KCNH5 | --------------ISSLFSSLKVVRLLRL>G<RVARKLDHY-----LEYGAAV-LVLLVCVF | 356 |
| KCNH6 | --T-------------TLIGLLKTARLLRL>V<RVARKLDRY-----SEYGAAV-LFLLMCTF | 408 |
| KCNH7 | --T-------------TLIGLLKTARLLRL>V<RVARKLDRY-----SEYGAAV-LMLLMCIF | 559 |
| KCNH8 | --V-------------SLVHLLKTVRLLRL>L<RLLQKLDRY-----SQHSTIV-LTLLMSMF | 363 |
| CNGA1 | ----------------PEIRLNRLLRFSRM>F<EFFQRTETR-----TNYPNIFRISNLVMYI | 307 |
| CNGA2 | ----------------PEVRFNRLLHFARM>F<EFFDRTETR-----TNYPNIFRISNLVLYI | 282 |
| CNGA3 | ----------------PEVRFNRLLKFSRL>F<EFFDRTETR-----TNYPNMFRIGNLVLYI | 310 |
| CNGA4 | ----------------PTLRLNRFLRAPRL>F<EAFDRTETR-----TAYPNAFRIAKLMLYI | 176 |
| CNGB1 | ----------------PLLRLPRCLKYMAF>F<EFNSRLESI-----LSKAYVYRVIRTTAYL | 798 |
| CNGB3 | ----------------PMFRANRMLKYTSF>F<EFNHHLESI-----MDKAYIYRVIRTTGYL | 360 |
| HCN1 | RFT-------------KILSLLRLLRLSRL>I<RYIHQWEEIFHMTYDLASAVVRIFNLIGMM | 305 |
| HCN2 | RFT-------------KILSLLRLLRLSRL>I<RYIHQWEEIFHMTYDLASAVMRICNLISMM | 374 |
| HCN3 | RFT-------------KILSLLRLLRLSRL>I<RYIHQWEEIFHMTYDLASAVVRIFNLIGMM | 258 |
| HCN4 | RFT-------------KILSLLRLLRLSRL>I<RYIHQWEEIFHMTYDLASAVVRIVNLIGMM | 425 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.V533G | c.1598T>G | Putative Benign | rs202102276 | SIFT: deleterious Polyphen: possibly damaging |